Assessment of olfactory and gustatory dysfunction in post-COVID dentists by a modified CCCRC
More details
Hide details
1
Oral Diagnosis Department, College of Dentistry, University of Baghdad, Iraq, Iraq
2
Oral Diagnostic sciences department, College of Dentistry, University of Baghdad, Oral medicine, Iraq, Iraq
Submission date: 2024-03-04
Final revision date: 2025-01-23
Acceptance date: 2025-03-15
Publication date: 2025-04-30
Wiadomości Lekarskie 2025;(4)
KEYWORDS
TOPICS
ABSTRACT
Aim:
Background: Sudden onset of anosmia and/or ageusia symptoms could be enough to isolate patients and vaccinated participants even without doing the COVID-19 test. Aims: One of the objective methods used to assess the changes in the chemical sense is the Connecticut Chemosensory Clinical Research Center Test.
Material and methods:
Materials and methods: A systematic informative questionnaire was filled out for each participant. Chemosensitive symptoms were recorded by using n-butyl alcohol and environmentally realistic odorants and calculated in a modified way for the detection of olfactory function. The gustatory test scoring was done using the four standard primary tastes.
Results:
Results: Out of 133 participants, dentists were more commonly females (81, 61%) with the majority below 35 years of age (97, 72%). Half of the participants experienced smell and/or taste loss during the COVID-19 pandemic; whereas almost all reported having had olfactory dysfunction (132, 99.2%) and (105, 78.2%) gustatory dysfunction. Males reported a higher significant rate of taste loss (P=0.009) and females showed a higher recovery rate within the first two weeks after the onset than males. The Pfizer vaccine showed a significantly more frequent smell loss than other vaccinations (P=0.038).
Conclusions:
Conclusion: Gender variation was noticed with taste and smell loss. Females recovered faster from dysfunction. Pfizer fully vaccinated participants were more prone to lose smell compared to others.